Epstein–Barr virus positive diffuse large B‐cell lymphoma transformed into angioimmunoblastic T‐cell lymphoma after treatment

Angioimmunoblastic T‐cell lymphoma (AITL) is the subtype of mature T‐cell non‐Hodgkin lymphoma. Compared with diffuse large B‐cell lymphoma (DLBCL), AITL patients are frequently accompanied with Epstein–Barr virus (EBV) infection. To date, there is no report on the subsequent development of AITL in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chaoyu, Gong, Yi, Jiang, Qingming, Liang, Xiping, Chen, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142414/
https://www.ncbi.nlm.nih.gov/pubmed/34084501
http://dx.doi.org/10.1002/ccr3.4083
_version_ 1783696545880735744
author Wang, Chaoyu
Gong, Yi
Jiang, Qingming
Liang, Xiping
Chen, Rui
author_facet Wang, Chaoyu
Gong, Yi
Jiang, Qingming
Liang, Xiping
Chen, Rui
author_sort Wang, Chaoyu
collection PubMed
description Angioimmunoblastic T‐cell lymphoma (AITL) is the subtype of mature T‐cell non‐Hodgkin lymphoma. Compared with diffuse large B‐cell lymphoma (DLBCL), AITL patients are frequently accompanied with Epstein–Barr virus (EBV) infection. To date, there is no report on the subsequent development of AITL in patients with EBV‐positive DLBCL. We performed a rare case of EBV‐positive AITL developing one year after initial diagnosis of EBV‐positive DLBCL. The patient showed poor response to the chemotherapy regimen, and poor survival.
format Online
Article
Text
id pubmed-8142414
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81424142021-06-02 Epstein–Barr virus positive diffuse large B‐cell lymphoma transformed into angioimmunoblastic T‐cell lymphoma after treatment Wang, Chaoyu Gong, Yi Jiang, Qingming Liang, Xiping Chen, Rui Clin Case Rep Case Reports Angioimmunoblastic T‐cell lymphoma (AITL) is the subtype of mature T‐cell non‐Hodgkin lymphoma. Compared with diffuse large B‐cell lymphoma (DLBCL), AITL patients are frequently accompanied with Epstein–Barr virus (EBV) infection. To date, there is no report on the subsequent development of AITL in patients with EBV‐positive DLBCL. We performed a rare case of EBV‐positive AITL developing one year after initial diagnosis of EBV‐positive DLBCL. The patient showed poor response to the chemotherapy regimen, and poor survival. John Wiley and Sons Inc. 2021-05-05 /pmc/articles/PMC8142414/ /pubmed/34084501 http://dx.doi.org/10.1002/ccr3.4083 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Wang, Chaoyu
Gong, Yi
Jiang, Qingming
Liang, Xiping
Chen, Rui
Epstein–Barr virus positive diffuse large B‐cell lymphoma transformed into angioimmunoblastic T‐cell lymphoma after treatment
title Epstein–Barr virus positive diffuse large B‐cell lymphoma transformed into angioimmunoblastic T‐cell lymphoma after treatment
title_full Epstein–Barr virus positive diffuse large B‐cell lymphoma transformed into angioimmunoblastic T‐cell lymphoma after treatment
title_fullStr Epstein–Barr virus positive diffuse large B‐cell lymphoma transformed into angioimmunoblastic T‐cell lymphoma after treatment
title_full_unstemmed Epstein–Barr virus positive diffuse large B‐cell lymphoma transformed into angioimmunoblastic T‐cell lymphoma after treatment
title_short Epstein–Barr virus positive diffuse large B‐cell lymphoma transformed into angioimmunoblastic T‐cell lymphoma after treatment
title_sort epstein–barr virus positive diffuse large b‐cell lymphoma transformed into angioimmunoblastic t‐cell lymphoma after treatment
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142414/
https://www.ncbi.nlm.nih.gov/pubmed/34084501
http://dx.doi.org/10.1002/ccr3.4083
work_keys_str_mv AT wangchaoyu epsteinbarrviruspositivediffuselargebcelllymphomatransformedintoangioimmunoblastictcelllymphomaaftertreatment
AT gongyi epsteinbarrviruspositivediffuselargebcelllymphomatransformedintoangioimmunoblastictcelllymphomaaftertreatment
AT jiangqingming epsteinbarrviruspositivediffuselargebcelllymphomatransformedintoangioimmunoblastictcelllymphomaaftertreatment
AT liangxiping epsteinbarrviruspositivediffuselargebcelllymphomatransformedintoangioimmunoblastictcelllymphomaaftertreatment
AT chenrui epsteinbarrviruspositivediffuselargebcelllymphomatransformedintoangioimmunoblastictcelllymphomaaftertreatment

Ejemplares similares